“We all love to buy pharma stocks when they release positive clinical data, but they can also be solid choices for investors looking for businesses… Read More »2 Pharma Stocks To Consider Picking Up On The Dip
“In light of the ongoing COVID-19 pandemic, a number of pharma companies have postponed new study starts and have paused enrollment/screening in their clinical trials.… Read More »3 Biotech/Pharma Stocks With Potential Clinical Trial Catalysts This Quarter
One of the most significant – and relatively recent – innovations in the treatment of cancer are so-called immuno-oncology (IO) drugs. As today’s article explains,… Read More »The Pharmaceutical Companies Experiencing Early Success With These “Miracle” Cancer Drugs
More than 10 years into this bull market, Buy and Outperform analyst ratings generally come with implied upside potential of 8% to 10%. However, the… Read More »20 Biotech And Pharma Stocks Offering More-Than-Your-Average Upside Potential
With only 10% of drug candidates that reach the clinical trial stage eventually making their way onto the market, knowing which small biotechs to bet… Read More »This Little-Known Biotech Is Attracting The Attention Of Big Pharma – And Creating An Opportunity For Investors